A comprehensive suite of services that empowers our clients to meet their communications and organizational goals. All of 3D’s services are provided by senior communications professionals with decades of C-suite level expertise. Our specialty is coaching executives and teams facing complex, controversial issues, in highly-regulated industries, to deliver mission-critical communications.Previous Play Video Next
3D’s speaker training experts will coach you to improve your public speaking and presentation skills and make a positive and lasting impression on the most important audiences.
3D’s Speaker Training includes:
Whether you’re chasing the media or the media are chasing you, 3D Communications can help. Our media training coaches help healthcare executives improve their media skills in the fast-changing world of 24/7, interactive media.
3D’s Media Training includes:
Great leaders are authentic leaders. Their personal values drive every decision they make. They are effective because they communicate their vision in a way that inspires action from others.
3D’s comprehensive Leadership Communications program is designed to help executives discover their authentic voice. We coach them on how to connect personal values to business goals and communicate powerfully and credibly.
3D’s Leadership Communications Training includes:
Change – however necessary – creates challenges for any organization. 3D helps clients to plan for change, develop internal and external content, and train executives on how to best communicate change to employees, communities and other stakeholders.
The result is a transition that increases employee loyalty and engagement, strengthens stakeholder relationships, and achieves the ultimate goal of successful change.
3D’s Change Management Communications includes:
No organization is immune to crisis. But why do some manage them more successfully than others? The most successful teams have planned and prepared for the worst, so they can leverage the situation to strengthen relationships and enhance reputations.
3D partners with clients to develop crisis communications plans, train personnel for potential crises, and provide real-time tactical execution services during a crisis. We successfully guide leaders through the most difficult times, enabling them to remain focused on high-level goals and objectives.
3D’s Crisis Communications Program includes:
3D develops content for a full range of verbal and written communications. Our professional writers and producers approach each project as a creative partnership. We marry our clients’ subject-matter knowledge and expertise, with our ability to translate complex information into an understandable narrative.
The result is messages, speeches, and presentations that can be easily delivered and clearly understood. When you work with 3D, your presentation will influence, persuade and inspire.
3D’s Messaging and Content Development includes:
As all of our work becomes increasingly global, it is interesting to note the significant social, cultural, language and other differences that make message development and communications training for different countries more challenging than ever. This is particularly true when the messages on a product or issue have to be consistent across a global organization, but at the same time, resonate with – and not offend — audiences in specific regions.
What can health care leaders do to make an impact and be remembered? They need to reach what I’m calling the new C-Suite. No, not that C-Suite located on the top floor filled with a company’s most important C-level executives, the CEO, COO, CFO… No, this C-Suite outlines the elements you need to master to achieve executive speaking success.
Last week, FDA and Amarin Corporation reached a negotiated settlement of a legal case concerning off-label promotion for use of a drug for an unapproved indication. The negotiation established parameters for how Amarin and the FDA will operationalize the Court’s finding that the FDA cannot stop a company from providing truthful and non-misleading information about unapproved new indications of a drug. What the Court decision and the negotiated settlement mean for the future of off-label new use promotion beyond Amarin will become clear over time. What this case prompts for me is perhaps the bigger question – and that is, how should FDA and life science companies consider the larger set of data issues that sit at the heart of our healthcare system’s transition from volume to value?
Following the results of the Amarin legal judgment, there has been speculation that the ability to promote unapproved, “off-label” claims for prescription drugs will dramatically change. Yet, there are specific reasons why the Amarin First Amendment legal case succeeded and hundreds, if not thousands, of other cases have failed. While the Amarin judgment has set a precedent, it should not have a dramatic change on promotional claim requirements in pharma marketing – meaning that companies do not have First Amendment protection for statements that are untruthful and misleading. It’s not expected that the FDA will diminish the criteria needed to support substantial evidence of efficacy. Instead they will continue to vigorously protect public health and the communication of accurate, science-based information.